Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Achieve Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Achieve Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Achieve Life Sciences, you can compare the effects of market volatilities on Virax Biolabs and Achieve Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Achieve Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Achieve Life.
Diversification Opportunities for Virax Biolabs and Achieve Life
The 3 months correlation between Virax and Achieve is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Achieve Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achieve Life Sciences and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Achieve Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achieve Life Sciences has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Achieve Life go up and down completely randomly.
Pair Corralation between Virax Biolabs and Achieve Life
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 3.33 times more return on investment than Achieve Life. However, Virax Biolabs is 3.33 times more volatile than Achieve Life Sciences. It trades about 0.35 of its potential returns per unit of risk. Achieve Life Sciences is currently generating about 0.28 per unit of risk. If you would invest 63.00 in Virax Biolabs Group on March 6, 2024 and sell it today you would earn a total of 41.00 from holding Virax Biolabs Group or generate 65.08% return on investment over 90 days.
Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.
Compared to the overall equity markets, risk-adjusted returns on investments in Achieve Life Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical indicators, Achieve Life showed solid returns over the last few months and may actually be approaching a breakup point.